TrialLancet (London, England)2014

Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial.

Marcia S Brose et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.